Abstract
Abstract
Telomeres, also known as the “protective caps” of our chromosomes, shorten with each cell cycle due to the end replication problem. This process, termed telomere attrition, is associated with many age-related disorders, such as Alzheimer’s disease (AD). Despite the numerous studies conducted in this field, the role of telomere attrition in the onset of the disease remains unclear. To investigate the causal relationship between short telomeres and AD, this review aims to highlight the primary factors that regulate telomere length and maintain its integrity, with an additional outlook on the role of oxidative stress, which is commonly associated with aging and molecular damage. Although some findings thus far might be contradictory, telomere attrition likely plays a crucial role in the progression of AD due to its close association with oxidative stress. The currently available treatments for AD are only symptomatic without affecting the progression of the disease. The components of telomere biology discussed in this paper have previously been studied as an alternative treatment option for several diseases and have exhibited promising in vitro and in vivo results. Hence, this should provide a basis for future research to develop a potential therapeutic strategy for AD.
Graphical Abstract
(Created with BioRender.com)
Funder
Kementerian Pendidikan Malaysia
Monash University Malaysia
Monash University
Publisher
Springer Science and Business Media LLC
Subject
Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology
Reference125 articles.
1. Yadav M, Pandey P, Sharma P (2022) Understanding the genetic, molecular, and cellular basis of ageing as the biggest risk factor of Alzheimer’s disease. Eur J Biol Res 12(1):62–76
2. Zhu XC, Tan L, Wang HF, Jiang T, Cao L, Wang C et al (2015) Rate of early onset Alzheimer’s disease: a systematic review and meta-analysis. Ann Transl Med 3(3):38
3. Gao K, Wei C, Zhu J, Wang X, Chen GQ, Luo YY, Zhang D, Yue WH et al (2019) Exploring the causal pathway from telomere length to Alzheimer’s disease: an update Mendelian randomization study. Front Psychiatry 10:843
4. Prince M, Wimo A, Guerchet M et al (2015) World alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International. https://www.alzint.org/u/WorldAlzheimerReport2015.pdf. Accessed June 2022
5. Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (2021) Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement 17(12):1966–1975
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献